Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Statistical Methods in Medical Research
|
June 1, 2022
Conversion of non-inferiority margin from hazard ratio to restricted mean survival time difference using data from multiple historical trials
Ruizhe Chen, Sanjib Basu, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2022
Reply to A. Smith et al
Elisa Fontana, Jeffrey P Meyers, Thierry André, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2015
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods
Ming-Wen An, Yu Han, Jeffrey P Meyers, et al.
Journal of Surgical Oncology
|
May 30, 2019
A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors
Yougen Wu, Jeffrey P Meyers, Guowei Shi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
July 23, 2013
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature
Krishna Patel, Nathan R Foster, Ann Farrell, et al.
The Oncologist
|
January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Journal of Geriatric Oncology
|
December 9, 2014
Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis
William G Rule, Nathan R Foster, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program
Christopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Cancer Causes & Control : CCC
|
May 27, 2019
Development and validation of a model to predict outcomes of colon cancer surveillance
Johnie Rose, Laura Homa, Chung Yin Kong, et al.
JAMA Oncology
|
December 23, 2016
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials
Frank A Sinicrope, Qian Shi, Carmen J Allegra, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Statistical Methods in Medical Research
|
June 1, 2022
Conversion of non-inferiority margin from hazard ratio to restricted mean survival time difference using data from multiple historical trials
Ruizhe Chen, Sanjib Basu, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2022
Reply to A. Smith et al
Elisa Fontana, Jeffrey P Meyers, Thierry André, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2015
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods
Ming-Wen An, Yu Han, Jeffrey P Meyers, et al.
Journal of Surgical Oncology
|
May 30, 2019
A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors
Yougen Wu, Jeffrey P Meyers, Guowei Shi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
July 23, 2013
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature
Krishna Patel, Nathan R Foster, Ann Farrell, et al.
The Oncologist
|
January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Journal of Geriatric Oncology
|
December 9, 2014
Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis
William G Rule, Nathan R Foster, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program
Christopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Cancer Causes & Control : CCC
|
May 27, 2019
Development and validation of a model to predict outcomes of colon cancer surveillance
Johnie Rose, Laura Homa, Chung Yin Kong, et al.
JAMA Oncology
|
December 23, 2016
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials
Frank A Sinicrope, Qian Shi, Carmen J Allegra, et al.
Page
of 3